Cellectar Biosciences (CLRB) Return on Assets [ROA] (2011 - 2026)
Cellectar Biosciences' Return on Assets [ROA] was -92.12% in Q2 2026, up 166.89 percentage points from -259.01% a year earlier.
Powered by 
Analysis
Cellectar Biosciences (CLRB) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Cellectar Biosciences came in at -107.74%, up 129.72 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of -64.61 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -237.45% in FY2024 (+16.64 pp), -254.09% in FY2023 (-145.94 pp), -108.15% in FY2022 (-57.83 pp) and -50.33% in FY2021 (-7.20 pp).
- The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] since Q2 2022.
- Compared with a year earlier, Return on Assets [ROA] was higher in four of the last seven quarters, with an average year-over-year change of +10.94 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q2 2024 (a gain of 170.15 percentage points); the worst was Q2 2023 (a drop of 214.54 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Cellectar Biosciences | 21.77 Mn | 21.77 Mn | - | -92.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -92.12% |
| Dec 31, 2025 | -155.24% |
| Sep 30, 2025 | -212.08% |
| Jun 30, 2025 | -259.01% |
| Mar 31, 2025 | -222.45% |
| Dec 31, 2024 | -164.98% |
| Sep 30, 2024 | -154.72% |
| Jun 30, 2024 | -131.87% |
| Mar 31, 2024 | -153.71% |
| Dec 31, 2023 | -231.73% |
| Sep 30, 2023 | -241.16% |
| Jun 30, 2023 | -302.02% |
| Mar 31, 2023 | -172.28% |
| Dec 31, 2022 | -140.87% |
| Sep 30, 2022 | -120.83% |
| Jun 30, 2022 | -87.48% |
| Mar 31, 2022 | -69.12% |
| Dec 31, 2021 | -60.97% |
| Sep 30, 2021 | -49.07% |
| Jun 30, 2021 | -39.10% |
API Access
Cellectar Biosciences Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CLRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "CLRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CLRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();